AUTOTAC Bio
Seoul
About AUTOTAC Bio
AUTOTAC Bio is a drug development company that creates protein target decomposition drugs for humans.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $16.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2020)
- Website: autotacbio.com
- Phone: +82 02 6951 1448
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/autotac-bio-50353 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.